EXTCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。EXT遺伝子サイレンサーは、EXT CRISPR/Cas9ノックアウトプラスミドとEXTDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のEXTCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
EXT CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EXT1 CRISPR/Cas9 KOプラスミド (h) | sc-404635 | h | Gene Knockout | GFP | 1 | ||
EXT1 HDRプラスミド (h) | sc-404635-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
EXT1 Double Nickaseプラスミド (h) | sc-404635-NIC | h | Gene Knockout | Puromycin | 1 | ||
EXT1 Double Nickaseプラスミド (h2) | sc-404635-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
EXT1 CRISPR/Cas9 KOプラスミド (m) | sc-420252 | m | Gene Knockout | GFP | 0 | ||
EXT1 HDRプラスミド (m) | sc-420252-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
EXT1 Double Nickaseプラスミド (m) | sc-420252-NIC | m | Gene Knockout | Puromycin | 0 | ||
EXT1 Double Nickaseプラスミド (m2) | sc-420252-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
EXT2 CRISPR/Cas9 KOプラスミド (h) | sc-406286 | h | Gene Knockout | GFP | 0 | ||
EXT2 HDRプラスミド (h) | sc-406286-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EXT2 Double Nickaseプラスミド (h) | sc-406286-NIC | h | Gene Knockout | Puromycin | 0 | ||
EXT2 Double Nickaseプラスミド (h2) | sc-406286-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EXT2 CRISPR/Cas9 KOプラスミド (m) | sc-420253 | m | Gene Knockout | GFP | 0 | ||
EXT2 HDRプラスミド (m) | sc-420253-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
EXT2 Double Nickaseプラスミド (m) | sc-420253-NIC | m | Gene Knockout | Puromycin | 0 | ||
EXT2 Double Nickaseプラスミド (m2) | sc-420253-NIC-2 | m | Gene Knockout | Puromycin | 0 |
EXT CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EXT1 CRISPR Activationプラスミド (h) | sc-404635-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EXT1 CRISPR Activationプラスミド (h2) | sc-404635-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EXT1 Lentiviral Activation Particles (h) | sc-404635-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EXT1 Lentiviral Activation Particles (h2) | sc-404635-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EXT1 CRISPR Activationプラスミド (m) | sc-420252-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT1 CRISPR Activationプラスミド (m2) | sc-420252-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT1 Lentiviral Activation Particles (m) | sc-420252-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT1 Lentiviral Activation Particles (m2) | sc-420252-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 CRISPR Activationプラスミド (h) | sc-406286-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 CRISPR Activationプラスミド (h2) | sc-406286-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 Lentiviral Activation Particles (h) | sc-406286-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 Lentiviral Activation Particles (h2) | sc-406286-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 CRISPR Activationプラスミド (m) | sc-420253-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 CRISPR Activationプラスミド (m2) | sc-420253-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 Lentiviral Activation Particles (m) | sc-420253-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EXT2 Lentiviral Activation Particles (m2) | sc-420253-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |